Header cover image

Polish Pharmaceuticals & Biotech Sustainable Track Record

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

2 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
IGNInno-Genezł10.551.4%-48.5%zł60.1mn/aP/E7.5xn/an/a
BLRBLIRTzł13.461.8%47.9%zł235.9mn/aP/E10.4xn/a7.4%
Page 1 of 1